Change in Preferred Drug List Status for Antihyperuricemics Drug Class

On April 22, 2024, the Texas Health and Human Services Commission (HHSC) removed the non-preferred status from products with the brand name Mitigare on the HHSC preferred drug list.

• Information for drug manufacturers:
  • eCOI Portal training materials available
• Information for pharmacies:
  • Provider Portal training materials available
  • Pharmacy Education Information and Opportunities
  • Pharmacy Email Addresses Must Be Current in PEMS
• Information for prescribers:
  • Prescriber Survey Opportunity About Texas Prescription Drug Monitoring Program Ends May 14